Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Identification of Cognitive Side-Effects of Immunotherapy

NCT06414278 is registered in ClinicalTrials.gov with Masonic Cancer Center, University of Minnesota as lead sponsor.

NCT NCT06414278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06414278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Identification of Cognitive Side-Effects of Immunotherapy
Lead sponsor
Masonic Cancer Center, University of Minnesota
Phase
Observational
Overall status
Recruiting
Start date
February 8, 2024
Completion date
February 21, 2028
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphatic system neoplasm, malignant solid neoplasm